2-Chloro-5-nitrobenzaldehyde
- CAS NO.:6361-21-3
- Empirical Formula: C7H4ClNO3
- Molecular Weight: 185.56
- MDL number: MFCD00007293
- EINECS: 228-830-0
- SAFETY DATA SHEET (SDS)
- Update Date: 2026-01-13 11:22:20
What is 2-Chloro-5-nitrobenzaldehyde?
Chemical properties
light yellow to beige-yellow crystalline powder
The Uses of 2-Chloro-5-nitrobenzaldehyde
2-Chloro-5-nitrobenzaldehyde was used in the synthesis of 5-nitro-2-(1H-pyrrol-1-yl)benzaldehyde.
General Description
2-Chloro-5-nitrobenzaldehyde undergoes condensation reaction with 2-methyl-1-propenylbenzimidazole to yield (E,Z)-2-(2-chloro-5-nitrostyryl)-1-(1-propenyl)benzimidazole. It reacts with 5-aminopyrazoles to yield symmetrical bispyrazolo[3,4-]pyridines.
Properties of 2-Chloro-5-nitrobenzaldehyde
| Melting point: | 75-77 °C (lit.) |
| Boiling point: | 276.5°C (rough estimate) |
| Density | 1.4791 (rough estimate) |
| refractive index | 1.6000 (estimate) |
| storage temp. | under inert gas (nitrogen or Argon) at 2-8°C |
| form | Crystalline Powder |
| color | Pale yellow |
| Sensitive | Air Sensitive |
| BRN | 743764 |
| CAS DataBase Reference | 6361-21-3(CAS DataBase Reference) |
| EPA Substance Registry System | Benzaldehyde, 2-chloro-5-nitro- (6361-21-3) |
Safety information for 2-Chloro-5-nitrobenzaldehyde
| Signal word | Warning |
| Pictogram(s) |
![]() Exclamation Mark Irritant GHS07 |
| GHS Hazard Statements |
H303:Acute toxicity,oral H315:Skin corrosion/irritation H319:Serious eye damage/eye irritation H335:Specific target organ toxicity, single exposure;Respiratory tract irritation |
| Precautionary Statement Codes |
P261:Avoid breathing dust/fume/gas/mist/vapours/spray. P264:Wash hands thoroughly after handling. P264:Wash skin thouroughly after handling. P280:Wear protective gloves/protective clothing/eye protection/face protection. P304+P340:IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing. P305+P351+P338:IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continuerinsing. P405:Store locked up. |
Computed Descriptors for 2-Chloro-5-nitrobenzaldehyde
| InChIKey | VFVHWCKUHAEDMY-UHFFFAOYSA-N |
2-Chloro-5-nitrobenzaldehyde manufacturer
SAKEM LLP
1Y
Phone:+91-9676889998
Whatsapp: +91-9676889998
product: 2-Chloro-5-nitrobenzaldehyde 98%
New Products
Mirtazapine Impurity C/Mirtazapine Lactam Impurity N,O-Dimethylhydroxylamine hydrochloride Tetrabutylammonium perchlorate N,N CARBONYL DIIMIDAZOLE 2-Amino-5-bromo-4-(trifluoromethyl)pyridine(RM for Indian lab) (RS)-beta-Amino-beta-(4-bromophenyl)propionic acid (R)-1-Benzyl-3-pyrrolidinecarbonitrile N-Nitroso hydroxy Cetrizine EP Impurity-A Noradrenaline EP Impurity D/Noradrenaline Methyl Ether Cetirizine EP Impurity A/Cetirizine CBHP Impurity Lantanoprost rc B Clidinium Bromide Impurity 2,2'-(5-methyl-1,3-phenylene)-di(2-Methylpropionitrile) 1-methyl amino-2,4-dinitro benzene 5-Methyl-1,3-benzenediacetonitrile 4-Fluorothiophenol (R)-BoroLeu-(+)-Pinanediol-CF3COOH 4-(5-amino-1-methyl-1h-benzoimidazol-2-yl)-butyric acid isopropyl ester. 3,4 Diethoxy Benzylcyanide 2-Chloro Benzylcyanide 3-chlorobenzyl cyanide 3,4 Dimethoxy Benzylcyanide valeronitrile 4-Bromo BenzylcyanideRelated products of tetrahydrofuran








You may like
-
2-Chloro-5-nitrobenzaldehyde 6361-21-3 98%View Details
6361-21-3 -
2-Chloro-5-nitrobenzaldehyde CAS 6361-21-3View Details
6361-21-3 -
2-Chloro-5-nitrobenzaldehyde CAS 6361-21-3View Details
6361-21-3 -
2-Chloro-5-nitrobenzaldehyde 98%View Details
6361-21-3 -
192110-67-2 NLT 95%View Details
192110-67-2 -
Cetirizine EP Impurity A/Cetirizine CBHP Impurity NLT 95%View Details
59872-62-1 -
.2005-04-1 N-Nitroso hydroxy Cetrizine EP Impurity-A NLT 95%View Details
.2005-04-1 -
145773-22-1 Lantanoprost rc B NLT 95%View Details
145773-22-1
Statement: All products displayed on this website are only used for non medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

